Work

Phase I/IIa trial of volasertib combined with decitabine in patients with acute myeloid leukemia (AML) ineligible for intensive therapy

Year: 2015

Type: article

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/j.clml.2015.04.043

Authors: Jorge E. Cortes, Nikolai Podoltsev, Sushmita Rajeswari, Zhenchao Guo, Tillmann Taube, Geoffrey L. Uy

Institutions: The University of Texas MD Anderson Cancer Center, Yale University, Boehringer Ingelheim (United States), Boehringer Ingelheim (Germany), Washington University in St. Louis

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2228611820

FWCI: 0.522

Cites:

Cited by: 2

Related to: 10